Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:2198-2203
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pons-Lladó, G.
Right arrow Articles by Narula, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pons-Lladó, G.
Right arrow Articles by Narula, J.

Myocardial cell damage in human hypertension

Guillem Pons-Lladó, MD*, Manel Ballester, MD*, Xavier Borrás, MD*, Francesc Carreras, MD*, Ignasi Carrió, MD{dagger}, Joaquín López-Contreras, MD{ddagger}, Alex Roca-Cusachs, MD{ddagger}, Jaume Marrugat, MD§ and Jagat Narula, MD, PhD||

* Servei de Cardiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
{dagger} Servei de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
{ddagger} Unitat d’Hipertensió del Servei de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
§ Institut Municipal d’Investigació Mèdica, Barcelona, Spain
|| Division of Cardiology, Allegheny University Hospitals, Philadelphia, Pennsylvania, USA



View larger version (13K):

[in a new window]
 
Figure 1 The correlation between left ventricular ejection fraction and the severity of myocardial damage detected by antimyosin antibody heart-to-lung uptake ratio in those 36 patients in whom reliable measures of ejection fraction by echocardiography were obtained. The area below the horizontal line represents normal range of antimyosin antibody heart-to-lung uptake ratio (<1.55). LV = left ventricular.

 


View larger version (14K):

[in a new window]
 
Figure 2 The correlation between the indexed LVM and the severity of myocardial damage detected by antimyosin antibody heart-to-lung uptake ratio in the 39 hypertensive patients. The area below the horizontal line represents the normal range of antimyosin antibody heart-to-lung uptake ratio (<1.55). There was a significant positive correlation between LVM index and the HLR (r = 0.72). Open squares = patients in group I (no LVH), solid squares = patients in group II (asymptomatic patients with LVH) and solid circles = patients in group III (symptomatic patients). HLR = heart-to-lung ratio; LV = left ventricle; LVH = left ventricular hypertrophy; LVM = left ventricular mass.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement